Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.
2.

A comprehensive examination of Smad4, Smad6 and Smad7 mRNA expression in pancreatic ductal adenocarcinoma.

Singh P, Wig JD, Srinivasan R, Radotra BD.

Indian J Cancer. 2011 Apr-Jun;48(2):170-4. doi: 10.4103/0019-509X.82876.

3.
4.

Yes-associated protein (YAP65) in relation to Smad7 expression in human pancreatic ductal adenocarcinoma.

Guo J, Kleeff J, Zhao Y, Li J, Giese T, Esposito I, Büchler MW, Korc M, Friess H.

Int J Mol Med. 2006 May;17(5):761-7.

PMID:
16596258
5.

Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.

Javle M, Li Y, Tan D, Dong X, Chang P, Kar S, Li D.

PLoS One. 2014 Jan 20;9(1):e85942. doi: 10.1371/journal.pone.0085942.

6.
7.

Molecular analyses of the 15q and 18q SMAD genes in pancreatic cancer.

Jonson T, Gorunova L, Dawiskiba S, Andrén-Sandberg A, Stenman G, ten Dijke P, Johansson B, Höglund M.

Genes Chromosomes Cancer. 1999 Jan;24(1):62-71.

PMID:
9892110
8.

Phosphatase PPM1A is a novel prognostic marker in pancreatic ductal adenocarcinoma.

Fan J, Yang MX, Ouyang Q, Fu D, Xu Z, Liu X, Mino-Kenudson M, Geng J, Tang F.

Hum Pathol. 2016 Sep;55:151-8. doi: 10.1016/j.humpath.2016.05.002.

PMID:
27195906
9.

Mutational analysis of TGF-beta type II receptor, Smad2, Smad3, Smad4, Smad6 and Smad7 genes in colorectal cancer.

Fukushima T, Mashiko M, Takita K, Otake T, Endo Y, Sekikawa K, Takenoshita S.

J Exp Clin Cancer Res. 2003 Jun;22(2):315-20.

PMID:
12866583
10.

Clinicopathological significance of SMAD4 loss in pancreatic ductal adenocarcinomas: a systematic review and meta-analysis.

Wang JD, Jin K, Chen XY, Lv JQ, Ji KW.

Oncotarget. 2016 Dec 28. doi: 10.18632/oncotarget.14335. [Epub ahead of print]

11.

Low-level expression of Smad7 correlates with lymph node metastasis and poor prognosis in patients with pancreatic cancer.

Wang P, Fan J, Chen Z, Meng ZQ, Luo JM, Lin JH, Zhou ZH, Chen H, Wang K, Xu ZD, Liu LM.

Ann Surg Oncol. 2009 Apr;16(4):826-35. doi: 10.1245/s10434-008-0284-5.

PMID:
19165547
12.

Prognostic significance of the expression of Smad4 and Smad7 in human gastric carcinomas.

Kim YH, Lee HS, Lee HJ, Hur K, Kim WH, Bang YJ, Kim SJ, Lee KU, Choe KJ, Yang HK.

Ann Oncol. 2004 Apr;15(4):574-80.

PMID:
15033661
13.

miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway.

Zhu Z, Xu Y, Zhao J, Liu Q, Feng W, Fan J, Wang P.

Br J Cancer. 2015 Apr 14;112(8):1367-75. doi: 10.1038/bjc.2015.102.

14.

SMAD4 genetic alterations predict a worse prognosis in patients with pancreatic ductal adenocarcinoma.

Singh P, Srinivasan R, Wig JD.

Pancreas. 2012 May;41(4):541-6. doi: 10.1097/MPA.0b013e318247d6af.

PMID:
22504380
15.

The TGF-β/Smad4 Signaling Pathway in Pancreatic Carcinogenesis and Its Clinical Significance.

Ahmed S, Bradshaw AD, Gera S, Dewan MZ, Xu R.

J Clin Med. 2017 Jan 5;6(1). pii: E5. doi: 10.3390/jcm6010005. Review.

16.

Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.

Oshima M, Okano K, Muraki S, Haba R, Maeba T, Suzuki Y, Yachida S.

Ann Surg. 2013 Aug;258(2):336-46. doi: 10.1097/SLA.0b013e3182827a65.

PMID:
23470568
17.

Expression of VEGF-D, SMAD4, and SMAD7 and Their Relationship with Lymphangiogenesis and Prognosis in Colon Cancer.

Su F, Li X, You K, Chen M, Xiao J, Zhang Y, Ma J, Liu B.

J Gastrointest Surg. 2016 Dec;20(12):2074-2082.

PMID:
27730400
18.

The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma.

Tascilar M, Skinner HG, Rosty C, Sohn T, Wilentz RE, Offerhaus GJ, Adsay V, Abrams RA, Cameron JL, Kern SE, Yeo CJ, Hruban RH, Goggins M.

Clin Cancer Res. 2001 Dec;7(12):4115-21.

19.

Expression of Smad4 and Smad7 in human thyroid follicular carcinoma cell lines.

Cerutti JM, Ebina KN, Matsuo SE, Martins L, Maciel RM, Kimura ET.

J Endocrinol Invest. 2003 Jun;26(6):516-21.

PMID:
12952364
20.

Inhibitory smads and tgf-Beta signaling in glomerular cells.

Schiffer M, Schiffer LE, Gupta A, Shaw AS, Roberts IS, Mundel P, Böttinger EP.

J Am Soc Nephrol. 2002 Nov;13(11):2657-66.

Supplemental Content

Support Center